| ID | Name | CAS | Properties |
Tfus (K) |
| 22-711-7 |
Androst-5-en-17-one, 3-[(trimethylsilyl)oxy]-, (3«beta»)-
|
3747-91-9 |
4 | 393.37 |
| 22-837-8 |
Androstan-17-one, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3«beta»,5«alpha»)-
|
57711-44-1 |
4 | 405.34 |
| 23-363-3 |
21-Hydroxypregn-4-en-3,20-dione, 20,21-methylboronate
|
|
4 | 406.43 |
| 23-577-6 |
5«alpha»-Androstan-17-one, 3«alpha»,11«beta»-bis(trimethylsiloxy)-
|
17562-92-4 |
4 | 379.74 |
| 23-731-4 |
5-Pregnen-3«beta»-ol-20-one, tert-butyldimethylsilyl ether
|
|
4 | 400.90 |
| 23-873-7 |
Androstan-17-one, 3-[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»)-
|
4867-14-5 |
4 | 394.27 |
| 24-406-4 |
1-Alpha-2-methyl-8-methoxy-6,7-methylenedioxy-1-(6,7-dimethoxy-3-phthalidyl)-1,2,3,4-tetrahydroisoquinoline
|
10421-76-8 |
4 | 407.52 |
| 25-777-2 |
N-tert-Butyl-6-chlor-[1,3,5]triazin-2,4-diamine
|
|
4 | 478.59 |
| 26-843-7 |
20«beta»,21-Dihydroxypregn-4-en-3-one, 20,21-bis-TMS
|
|
4 | 375.66 |
| 27-640-1 |
Silane, dimethyl(trans-3,7-dimethyl-2,6-octadien-1-yloxy)isohexyloxy-
|
|
4 | 204.49 |
| 27-739-2 |
1-«beta»,3-«alpha»,7-«beta»-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
4 | 375.19 |
| 28-354-8 |
3«beta»-Hydroxy-7«alpha»-methoxycholanic acid, methyl ester, TMS
|
|
4 | 382.29 |
| 29-039-7 |
3«beta»,4«beta»-dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 373.28 |
| 30-482-3 |
3-«beta»-Hydroxy-D-homo-5-androsten-17-one, TMS
|
|
4 | 378.72 |
| 31-293-2 |
3«alpha»,4«beta», 7«alpha»-trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 372.93 |
| 31-901-6 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«alpha»-triol, methylboronate
|
|
4 | 433.38 |
| 31-938-6 |
Phosphorothioic acid, O-(1,6-dihydro-6-oxo-1-phenyl-3-pyridazinyl) O,O-diethyl ester
|
119-12-0 |
4 | 328.15 |
| 32-154-5 |
11B-Hydroxyandrosterone (5A-Androstan-3A,11B-diol-17-one), TMS
|
|
4 | 381.05 |
| 32-486-7 |
4-Androsten-17«alpha»-ol-3-one (epitestosterone), MO-TMS
|
|
4 | 368.05 |
| 33-052-7 |
21-Hydroxypregn-4-en-3,20-dione, bis-MO-21-TMS
|
|
4 | 376.38 |
| 33-499-2 |
O-(2,4,5-trichlorophenyl) n,n,n',n'-tetramethyldiamidothiophosphate
|
|
4 | 380.83 |
| 35-066-0 |
3-«beta»,12-«alpha»-Dihydroxy-5-«alpha»-cholanoic acid, MeTMS
|
|
4 | 365.70 |
| 35-475-6 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»-diol, bis-TMS
|
|
4 | 375.52 |
| 35-516-0 |
3«beta»-Hydroxy-7«beta»-methoxycholanic acid, methyl ester, TMS
|
|
4 | 382.29 |
| 35-705-0 |
5-«beta»-Cholanoic acid, 3-«alpha»,4-«beta»,7-«alpha»-trihydroxy, methyl ester, TMS
|
|
4 | 372.93 |
| 36-008-3 |
2-Acetamido-2-([(trimethylsilyl)oxy]methyl)propane-1,3-diyl diacetate
|
|
4 | 333.87 |
| 36-739-2 |
17«alpha»-Methyl-17«beta»-hydroxy-1,4-androstadien-3-one, trimethylsilyl deriv.
|
41235-52-3 |
4 | 399.71 |
| 36-817-5 |
1H-Indole-3-ethanol, 2-(5-ethenyl-1-azabicyclo[2.2.2]oct-2-yl)-, [1S-(1«alpha»,2«alpha»,4«alpha»,5«beta»)]-
|
482-28-0 |
4 | 459.15 |
| 37-043-3 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-17keto,4«alpha»-ol, monoTBDMS
|
|
4 | 418.06 |
| 37-814-7 |
Cholan-24-oic acid, 3,12-bis[(trimethylsilyl)oxy]-, methyl ester, (3«alpha»,5«beta»,12«alpha»)-
|
6818-41-3 |
4 | 365.70 |
| 39-541-8 |
17«alpha»,21-Dihydroxypregn-4-en-3,20-dione, bis-MO-21-TMS
|
|
4 | 400.29 |
| 39-674-1 |
3-.beta.,19-Dihydroxy-5-androsten-17-one, MO TMS
|
|
4 | 372.08 |
| 39-938-8 |
3«alpha»,12«beta»-Dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
4 | 365.70 |
| 40-031-2 |
3-«beta»,12-«alpha»-Dihydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
4 | 365.70 |
| 40-191-5 |
2-Propanone, [(9-beta-d-ribofuranosyl-9h-purin-6-yl)thio]-
|
|
4 | 433.93 |
| 40-587-6 |
Cinchonan-9-ol, 10,11-dihydro-6'-methoxy-, (8«alpha»,9R)-
|
522-66-7 |
4 | 486.74 |
| 40-908-9 |
3«alpha»-Hydroxy-5«alpha»-pregnan-20-one, O-trimethylsilyl
|
18880-80-3 |
4 | 394.12 |
| 40-944-9 |
Androst-4-en-3-one, 17-[(trimethylsilyl)oxy]-, O-methyloxime, (17«beta»)-
|
56210-83-4 |
4 | 368.05 |
| 41-133-8 |
Trisilane,1,1,1,2,3,3,3-heptamethyl-2-(trimethylsilyl)-
|
|
4 | 284.58 |
| 41-139-2 |
Androstan-17-one, 3-[(trimethylsilyl)oxy]-, (3«beta»,5«beta»)-
|
10426-96-7 |
4 | 394.27 |
| 41-590-1 |
2-keto,3-methyl-5.alpha.-androstan-17.beta.-ol, monoTMS
|
|
4 | 402.36 |
| 42-130-0 |
Androst-4-en-17«alpha»-methyl-17«beta»-ol-3-one, TMS
|
|
4 | 382.73 |
| 42-377-7 |
17«alpha»,21-Dihydroxypregn-4-en-3,20-dione, bis-MO-21-TMS(d9)
|
|
4 | 400.29 |
| 42-392-0 |
4H-1-Benzopyran-4-one, 5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-
|
19103-54-9 |
4 | 463.92 |
| 42-488-4 |
5-«alpha»-Pregnane-17-«alpha»,20-«alpha»-diol, bis-TMS
|
|
4 | 375.52 |
| 42-492-9 |
5«beta»-Androstane-3,17-dione, mono-TMS, (2-en)
|
|
4 | 383.54 |
| 42-738-6 |
5«beta»-pregnane-3«alpha»,17«alpha»,20«beta»-triol, 17,20-methylboronate
|
|
4 | 449.54 |
| 42-986-1 |
3«alpha»,7«alpha»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | 357.46 |
| 43-021-0 |
Phosphoro diamidic acid, n,n'-bis (2,4-dimethyl phenyl), ethyl ester
|
|
4 | 403.76 |
| 43-060-7 |
7-Chloro-3-methyl-quinoline-8-carboxylic acid, butyl ester
|
|
4 | 306.17 |
| 43-393-8 |
(17«beta»)-2,3-Dimethoxy-17-[(trimethylsilyl)oxy]estra-1(10),2,4-triene
|
|
4 | 391.37 |
| 43-935-6 |
N-tert-Butyl-N'-acetyl-6-chloro-1,3,5-triazine-2,4-diamine
|
|
4 | 468.16 |
| 44-815-8 |
6-Chloro-N,N'-(cyclopropyl)-[1,3,5]triazine-2,4-diamine
|
|
4 | 446.33 |
| 45-215-3 |
6-Chloro-2-methyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
|
90606-97-6 |
4 | 522.03 |
| 45-216-2 |
3«beta»,16«alpha»-dihydroxy-5-androsten-17-one, TMS
|
|
4 | 393.09 |
| 45-619-5 |
3-«alpha»,12-«alpha»-Dihydroxy-5-«alpha»-cholanoic acid, MeTMS
|
|
4 | 365.70 |
| 45-802-1 |
3«alpha»,12«alpha»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | 343.26 |
| 46-390-8 |
3«beta»,4«beta», 7«alpha»-trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 372.93 |
| 46-908-3 |
3«alpha»,7«beta»-Dihydroxy-5«beta»-homocholanoic acid, MeTMS
|
|
4 | 386.72 |
| 47-566-2 |
Iron,[(2,3,5,6-«eta»)-bicyclo[2.2.1]hepta-2,5-diene]tricarbonyl-
|
12307-07-2 |
4 | 386.18 |
| 47-657-1 |
3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-
|
|
4 | 369.15 |
| 48-043-1 |
O,O-Dimethyl O-(2,4,5-trichloro)phenyl phosphate
|
3983-45-7 |
4 | 332.25 |
| 48-545-4 |
Carbamic acid, dimethyl-, 2-(formylmethylamino)-5,6-dimethyl-4-pyrimidinyl ester
|
27218-04-8 |
4 | 353.52 |
| 49-566-0 |
Androst-2,4-dien-3,17«beta»-diol, (3,17-O)-diTBDMSi
|
|
4 | 387.94 |
| 49-725-3 |
N-isobutyl-2-(trimethylsilyloxy]-4,5-dihydro-1H-imidazole-1-carboxamide
|
|
4 | 310.95 |
| 50-501-9 |
5«beta»-Androstan-17-one, 3«alpha»,11«beta»-bis(trimethylsiloxy)-
|
17562-89-9 |
4 | 379.74 |
| 50-917-8 |
Silane, [[(17«beta»)-2-methoxyestra-1,3,5(10)-triene-3,17-diyl]bis(oxy)]bis[trimethyl-
|
29825-47-6 |
4 | 384.80 |
| 51-409-1 |
17-Epimetandienone (Androst-1,4-dien-17B-methyl-17A-ol-3-one), TMS
|
|
4 | 399.71 |
| 51-755-7 |
17«alpha»,20«beta»,21-Trihydroxypregn-4-en-3-one, methylboronate
|
|
4 | 429.55 |
| 52-766-4 |
5«beta»-Cholane-3«alpha»,7«alpha»,24-triol, TMS
|
|
4 | 365.74 |
| 53-570-0 |
17.alpha.,21-Dihydroxypregn-4-en-3,20-dione, 17,21-dimethylsilylene
|
|
4 | 418.18 |
| 53-652-9 |
17-«alpha»-Hydroxy-17-«beta»-methyl-5-«beta»-androstan-3-one, 17-TMS
|
|
4 | 402.79 |
| 54-943-5 |
O-methyl,o-(2,4,5,-trichlorophenyl)-tert-butyl phosphoramidothioate
|
16805-76-8 |
4 | 359.23 |
| 55-533-9 |
1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-
|
642-72-8 |
4 | 433.15 |
| 56-004-5 |
17«alpha»,20«beta»,21-Trihydroxypregn-4-en-3-one, bis-TMS
|
|
4 | 401.21 |
| 56-144-0 |
3«alpha»-hydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | 359.47 |
| 56-164-8 |
5«beta»-Androst-1-ene-3,17-dione, mono-TMS
|
|
4 | 382.99 |
| 57-666-0 |
Androst-4-en-3-one, 17-[(trimethylsilyl)oxy]-, (17«alpha»)-
|
16134-45-5 |
4 | 375.75 |
| 59-880-0 |
Methyltestosterone (Androst-4-en-17A-methyl-17B-ol-3-one), TMS
|
|
4 | 382.73 |
| 60-846-6 |
9H-purine, 6-chloro-9-(2',3'-o-isopropylidene-beta-d-ribofuranosyl)-
|
39824-26-5 |
4 | 414.28 |
| 60-850-1 |
Phosphorothioic acid, O,O-diethyl O-(p-methylsulfonyl)phenyl ester
|
14255-72-2 |
4 | 329.24 |
| 62-409-9 |
N-tert-Butyl-N'-trimethylsilyl-6-methoxy-1,3,5-triazine-2,4-diamine
|
|
4 | 393.33 |
| 62-475-6 |
3-«beta»,17-«beta»-Dihydroxy-5-androsten-16-one, TMS
|
|
4 | 401.16 |
| 62-513-3 |
R,S-3',4'-methylenedioxy-«alpha»-pyrrolidinopropiophenone-M (desmethylene-methyl-), TMS
|
|
4 | 369.09 |
| 62-557-5 |
Phosphoramidothioic acid, o-ethyl-o-(2,4,5-trichlorophenyl) ester
|
2775-95-3 |
4 | 357.29 |
| 62-839-2 |
(4,6-Dichloro-[1,3,5]triazin-2-yl)-(1,1,3,3-tetramethyl-butyl)-amine
|
|
4 | 427.82 |
| 63-024-5 |
Phosphorothioic acid, O-(6-ethoxy-2-ethyl-4-pyrimidinyl) O,O-dimethyl ester
|
38260-54-7 |
4 | 269.80 |
| 63-477-3 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»,21-triol, tris-TMS
|
|
4 | 354.02 |
| 63-483-6 |
1,1,1-tris(Hydroxymethyl)propane, bis(tert-butyldimethylsilyl) ether
|
|
4 | 346.44 |
| 64-045-1 |
1-(4-Chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol, trimethylsilyl- ether
|
|
4 | 319.11 |
| 64-108-1 |
5-Chloro-N-(2-chloro-4-nitro-phenyl)-N-trimethylsilyl-2-trimethylsilyloxybenzamide
|
|
4 | 365.24 |
| 64-755-3 |
N2-Cyclopropyl-1,3,5-triazine-2,4,6-triamine N4,N6-diacetyl
|
|
4 | 475.26 |
| 64-949-8 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«beta»-triol, methylboronate
|
|
4 | 433.38 |
| 65-196-3 |
Cinnamic acid, 4-methoxy-3-(tert-butyldimethylsilyl)oxy-, tert-butyldimethylsilyl ester
|
|
4 | 381.96 |
| 65-250-2 |
3«alpha»,16«beta»-Dihydroxy-5-androsten-17-one, di-TMS
|
|
4 | 393.09 |
| 65-893-9 |
Androstane-11,17-dione, 3-[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»)-
|
5042-90-0 |
4 | 412.86 |
| 66-380-7 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»,21-triol, methylboronate
|
|
4 | 420.73 |
| 66-828-0 |
O-methyl,o-(2,4,5-trichlorophenyl)n-ethyl phosphoramidothioate
|
|
4 | 333.76 |
| 66-881-1 |
Ethanimidothioic acid, 2-(dimethylamino)-N-hydroxy-2-oxo-, methyl ester
|
30558-43-1 |
4 | 355.15 |
| 66-948-7 |
1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole
|
|
4 | 331.65 |
|
« Previous Results
Next Results »
|